Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause Oxygen saturation decreased? 32 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Oxygen saturation decreased have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.2% of all adverse event reports for SITAGLIPTIN.

32
Reports of Oxygen saturation decreased with SITAGLIPTIN
0.2%
of all SITAGLIPTIN reports
8
Deaths
11
Hospitalizations

How Dangerous Is Oxygen saturation decreased From SITAGLIPTIN?

Of the 32 reports, 8 (25.0%) resulted in death, 11 (34.4%) required hospitalization, and 7 (21.9%) were considered life-threatening.

Is Oxygen saturation decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 32 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause Oxygen saturation decreased?

TREPROSTINIL (3,865) RITUXIMAB (3,139) AMBRISENTAN (1,791) MACITENTAN (1,666) TOCILIZUMAB (1,501) METHOTREXATE (971) PREDNISONE (880) PACLITAXEL (833) ADALIMUMAB (813) SELEXIPAG (810)

Which SITAGLIPTIN Alternatives Have Lower Oxygen saturation decreased Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All Oxygen saturation decreased Reports All Drugs Causing Oxygen saturation decreased SITAGLIPTIN Demographics